Bioventus earnings were $28.5M for the trailing 12 months ending Mar 28, 2026, with N/A growth year over year. The latest BVS earnings report on Mar 28, 2026 announced Q1 2026 earnings of $3.1M, down 78.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BVS reported annual earnings of $22.7M, with -162.9% growth. The next BVS earnings date is Aug 5, 2026.
Bioventus (NASDAQ: BVS) reported Q1 2026 earnings per share (EPS) of $0.05, up 225% year over year. Total BVS earnings for the quarter were $3.11 million. In the same quarter last year, Bioventus's earnings per share (EPS) was -$0.04.
The next BVS earnings date is Aug 5, 2026. Add BVS to your watchlist to be reminded of Bioventus's next earnings date.
Is Bioventus profitable or losing money?
As of the last Bioventus earnings report, Bioventus is currently profitable. Bioventus's net profit (also called net income) for the twelve months ending Mar 28, 2026 was $28.48 million, a 184.09% decrease year over year.
What was BVS's earnings growth in the past year?
As of Bioventus's earnings date in Q3 2026, Bioventus's earnings has grown year over year. BVS earnings in the past year totalled $28.48 million.
What are Bioventus's earnings expectations?
The current EPS estimate for Bioventus's earnings report in Aug 5, 2026 is $0.22.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.